Robert W Postma - Director at Alaunos Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
TCRT on Nasdaq
All Insider Reports
All Insider Reports

Robert W Postma - trading volume in the past year for Alaunos Therapeutics, Inc.

Holdings reported by Robert W Postma for Alaunos Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 62,416 $204,724 $3.28 12 Jan 2026 By WaterMill Asset Management Corp.
Common Stock 43,872 $126,790 $2.89 12 Jan 2026 Direct
Series A-2 Convertible Preferred Stock 600 $2,694 $4.49 24 Jun 2025 By Watermill Asset Management Corp Common Stock
Series A-1 Convertible Preferred Stock 500 $1,380 $2.76 11 Apr 2025 By WaterMill Asset Management Corp. Common Stock
Common Stock 24 $78 $3.28 12 Jan 2026 By spouse's IRA
Employee Stock Option (right to buy) 6,400 03 Jul 2025 Direct Common Stock

Transactions reported by Robert W Postma for Alaunos Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.